Cargando…
Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study
Psoriasis, vitiligo and lichen planus (LP) are autoimmune skin diseases associated with metabolic syndrome. Angiopoietin-like 4 (ANGPTL4) is a member of angiopoietin-like proteins, which play an important role in lipid metabolism, and its serum concentration has been proposed as a biomarker of cardi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500972/ https://www.ncbi.nlm.nih.gov/pubmed/36144281 http://dx.doi.org/10.3390/metabo12090877 |
_version_ | 1784795355494219776 |
---|---|
author | Nowowiejska, Julia Baran, Anna Hermanowicz, Justyna Magdalena Mikłosz, Joanna Kamiński, Karol Adam Kondraciuk, Marcin Dubatówka, Marlena Pawlak, Dariusz Flisiak, Iwona |
author_facet | Nowowiejska, Julia Baran, Anna Hermanowicz, Justyna Magdalena Mikłosz, Joanna Kamiński, Karol Adam Kondraciuk, Marcin Dubatówka, Marlena Pawlak, Dariusz Flisiak, Iwona |
author_sort | Nowowiejska, Julia |
collection | PubMed |
description | Psoriasis, vitiligo and lichen planus (LP) are autoimmune skin diseases associated with metabolic syndrome. Angiopoietin-like 4 (ANGPTL4) is a member of angiopoietin-like proteins, which play an important role in lipid metabolism, and its serum concentration has been proposed as a biomarker of cardiometabolic complications, especially coronary artery disease (CAD). The study involved 56 patients with abovementioned dermatoses and 29 sex- and age-matched volunteers without dermatoses. ANGPTL4 serum concentration was measured by ELISA. ANGPTL4 concentration was statistically significantly higher in patients with LP compared to the control group (p < 0.01); moreover, it was significantly higher than in patients with psoriasis and vitiligo (p < 0.001, p < 0.01, respectively). There was no statistically significant difference in ANGPTL4 concentration between patients with psoriasis or vitiligo and controls. There was no correlation between ANGPTL4 concentration and age or BMI in all study groups. There was a positive correlation between ANGPTL4 concentration and fasting glucose (R = 0.43) and AST activity (R = 0.39) in psoriatic patients and ALT activity in patients with vitiligo (R = 0.44). ANGPTL4 could be a potential marker of metabolic complications in patients with LP, especially CAD. Perhaps patients with LP are more prone to CAD compared to the other two dermatoses, which requires further research. |
format | Online Article Text |
id | pubmed-9500972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95009722022-09-24 Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study Nowowiejska, Julia Baran, Anna Hermanowicz, Justyna Magdalena Mikłosz, Joanna Kamiński, Karol Adam Kondraciuk, Marcin Dubatówka, Marlena Pawlak, Dariusz Flisiak, Iwona Metabolites Communication Psoriasis, vitiligo and lichen planus (LP) are autoimmune skin diseases associated with metabolic syndrome. Angiopoietin-like 4 (ANGPTL4) is a member of angiopoietin-like proteins, which play an important role in lipid metabolism, and its serum concentration has been proposed as a biomarker of cardiometabolic complications, especially coronary artery disease (CAD). The study involved 56 patients with abovementioned dermatoses and 29 sex- and age-matched volunteers without dermatoses. ANGPTL4 serum concentration was measured by ELISA. ANGPTL4 concentration was statistically significantly higher in patients with LP compared to the control group (p < 0.01); moreover, it was significantly higher than in patients with psoriasis and vitiligo (p < 0.001, p < 0.01, respectively). There was no statistically significant difference in ANGPTL4 concentration between patients with psoriasis or vitiligo and controls. There was no correlation between ANGPTL4 concentration and age or BMI in all study groups. There was a positive correlation between ANGPTL4 concentration and fasting glucose (R = 0.43) and AST activity (R = 0.39) in psoriatic patients and ALT activity in patients with vitiligo (R = 0.44). ANGPTL4 could be a potential marker of metabolic complications in patients with LP, especially CAD. Perhaps patients with LP are more prone to CAD compared to the other two dermatoses, which requires further research. MDPI 2022-09-17 /pmc/articles/PMC9500972/ /pubmed/36144281 http://dx.doi.org/10.3390/metabo12090877 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Nowowiejska, Julia Baran, Anna Hermanowicz, Justyna Magdalena Mikłosz, Joanna Kamiński, Karol Adam Kondraciuk, Marcin Dubatówka, Marlena Pawlak, Dariusz Flisiak, Iwona Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title | Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title_full | Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title_fullStr | Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title_full_unstemmed | Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title_short | Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study |
title_sort | angiopoietin-like 4 (angptl4) in patients with psoriasis, lichen planus and vitiligo—a pilot study from the bialystok+ polish longitudinal university study |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500972/ https://www.ncbi.nlm.nih.gov/pubmed/36144281 http://dx.doi.org/10.3390/metabo12090877 |
work_keys_str_mv | AT nowowiejskajulia angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT barananna angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT hermanowiczjustynamagdalena angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT mikłoszjoanna angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT kaminskikaroladam angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT kondraciukmarcin angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT dubatowkamarlena angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT pawlakdariusz angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy AT flisiakiwona angiopoietinlike4angptl4inpatientswithpsoriasislichenplanusandvitiligoapilotstudyfromthebialystokpolishlongitudinaluniversitystudy |